跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Authorized
STANDARD
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Jamp Pharma Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
33f6ef6cd66c9ab5
Company
Jamp Pharma Corporation
Type
Standard
Approval Details
Approval Id
33f6ef6cd66c9ab5
Drug Approval Canada Name
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Product Name
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Status
Dormant
Status Date
2024-07-31
Original Market Date
2021-05-06
Din
02509164
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01AA09 BENDAMUSTINE
Atc Name
l 01 aa 09
Aig Number
0153268001
Company Name
Jamp Pharma Corporation
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Company Detail Path
/organization/jamp-pharma-corporation
Company Information
Pharmaceutical Company Name
Jamp Pharma Corporation
Country Name
Canada
Province Name
British Columbia
City Name
chilliwack,british columbia,country_ca
Address
8065 Aitken Rd
Active Ingredients
BENDAMUSTINE HYDROCHLORIDE
25 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
33f6ef6cd66c9ab5
Type
Standard
Back to Health Canada Approvals